AKT1 and neoplasm: Pathogenic autoantibodies targeting tumor-associated surface antigens can activate pro-survival signaling cascades (e.g., PI3K/Akt and MAPK pathways), thereby enhancing tumor cell proliferation, epithelial-mesenchymal transition, and metastatic dissemination (42).